Breast Cancer Tissue Microarray for Cancer Research
Tissue microarrays (TMAs) are high-efficiency research tools that embed multiple tissue samples into a single paraffin block, allowing researchers to analyze large cohorts under uniform experimental conditions. A breast cancer tissue microarray enables the investigation of tumour biology across various subtypes such as luminal A/B, HER2-enriched, and triple-negative breast cancers. It supports the identification of prognostic and predictive biomarkers, evaluation of tumour heterogeneity, and development of targeted therapies—all using a cost-effective, standardized format.
Breast cancer TMAs are most commonly used in immunohistochemistry (IHC) and hematoxylin and eosin (H&E) staining. IHC is essential for detecting markers such as estrogen receptor (ER), progesterone receptor (PR), HER2, and Ki-67, which are critical for subtype classification and treatment planning. H&E staining offers a clear view of tissue architecture, cell morphology, and tumour grading. Together, these methods provide comprehensive insights into tumour pathology, making TMAs indispensable in both basic research and translational oncology.
Role of Tissue Microarrays in TME Research
Tissue microarrays have transformed how researchers explore the tumour microenvironment (TME). They enable high-throughput analysis of multiple tissue samples simultaneously, making them essential for identifying biomarkers, conducting immune profiling, and performing spatial analysis. TMAs allow researchers to map immune cell infiltration, tumour heterogeneity, and stromal interactions across a broad cohort. Because human-derived TMAs preserve spatial organization, they provide a more accurate representation of the TME compared to animal models. This accelerates the validation of predictive biomarkers and improves the understanding of therapy response, ultimately pushing forward the development of personalised cancer treatment strategies.
Why Choose MYmAb Biologics' Tissue Microarray Over Others
What sets MYmAb Biologics apart is more than just technical quality. It’s the depth and relevance of our source material:
- SEA Sourced Sample: Our tissue microarrays are sourced from Southeast Asian samples, offering distinct population-specific insights that are often missing from Western-focused arrays.
- Fully Consented: Every sample comes from donors who have given informed consent, supporting ethical research standards.
- Comprehensive Data: Each array is curated for metadata richness, covering tumour type, grade, stage, and patient demographics when available.
- Global Delivery: We deliver worldwide with reliable logistics and clear documentation, making our TMAs accessible to researchers everywhere.
我们还提供以下专业服务
